Pharmacosmos at ESPHM Symposium 2014

May 1, 2014

Pharmacosmos participates in the 6th ESPHM Symposium (European Symposium of Porcine Health Management). The 2014 ESPHM Symposium is held in Sorrento, Italy, during the period May 7 - 9, 2014.

Pharmacosmos and the IEB (Iron Expert Board) will present a poster on the 8th of May at 11.25 - 11.45. The subject of the poster is: Early indicators of iron deficiency in piglets at weaning.

For additional information about the 2014 ESPHM Symposium, please visit: ESPHM 2014 Website

About Uniferon

Uniferon is a modern improved iron hydrogenated dextran based on a natural formula, which is approved for global use:

Uniferon is manufactured without the use of any organic solvents or cyanide, thus, avoiding trace residues of these impurities. Pharmacosmos manufactures iron dextran of high quality and unique purity for customers worldwide. Uniferon is the only injectable iron brand for piglets approved in the EU, the US and Asia.

About Pharmacosmos

Headquartered in Denmark, Pharmacosmos is a family-owned, international healthcare company with more than 50 years of innovation and leadership in iron- and carbohydrate-based treatments and solutions for human and animal use.

A research-based company, its ongoing R&D programme focuses on improving the lives of patients with iron deficiency with or without anaemia. More than 1 billion people live with iron deficiency anaemia and it is the leading cause of death for an estimated 180,000 people every year. This makes it one of the largest global health challenges of our time.

Pharmacosmos has subsidiaries in the Nordics, the UK and the US and its products are marketed in more than 80 countries across the world. Its manufacturing facilities are approved, among others, by the Danish Medicines Agency and the US FDA.